"10.1371_journal.pone.0120754","plos one","2015-03-27T00:00:00Z","Francesco Patti; Manuela De Stefano; Luigi Lavorgna; Silvia Messina; Clara Grazia Chisari; Domenico Ippolito; Roberta Lanzillo; Veria Vacchiano; Sabrina Realmuto; Paola Valentino; Gabriella Coniglio; Maria Buccafusca; Damiano Paolicelli; Alessandro D’Ambrosio; Patrizia Montella; Vincenzo Brescia Morra; Giovanni Savettieri; Bruno Alfano; Antonio Gallo; Isabella Simone; Rosa Viterbo; Mario Zappia; Simona Bonavita; Gioacchino Tedeschi","Department G.F. Ingrassia, Section of Neurosciences, University of Catania, Catania, Italy; Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Naples, Italy; Department of Neurological Sciences, University ‘Federico II,’ Naples, Italy; Department of Experimental Biomedicine and Clinical Neurosciences-University of Palermo, Palermo, Italy; Department of Medical Sciences, Institute of Neurology, University “Magna Graecia”, Catanzaro, Italy; Department of Neurology, “Madonna delle Grazie” Hospital, Matera, Italy; Department of Neurosciences, Psychiatry and Anaesthesiology, University of Messina, Messina, Italy; Department “Scienze Mediche di Base, Neuroscienze e Organi di Senso”, University of Bari, Bari, Italy; Biostructure and Bioimaging Institute, National Research Council, Naples, Italy; Neurological Institute for Diagnosis and Care “Hermitage Capodimonte”, Naples, Italy","Conceived and designed the experiments: FP LL SB GT MZ GS IS RL PV VB. Performed the experiments: CGC DI VV SR GC MB DP AD PM BA AG RV. Analyzed the data: MD SM FP LL. Contributed reagents/materials/analysis tools: CGC DI VV SR. Wrote the paper: FP MD LL SM GT.","The authors of this manuscript have the following competing interests: Dr. Patti has received honoraria for scientific lectures from Biogen Idec; Dr. De Stefano report no disclosure; Dr. Lavorgna has received travel payment from Merck-Serono, Novartis and Biogen Idec; Dr. Messina has received travel payment from Novartis, Biogen Idec, Bayer Schering, Merck Serono; report no disclosure; Drs Chisari, Ippolito, Vacchiano, Valentino, Buccafusca, Paolicelli, D’Ambrosio, Montella, Viterbo, Realmuto and Prof. Alfano report no disclosure; Dr Lanzillo has received travel payment from Merck-Serono, Novartis, Biogen Idec, Schering-Plough and Teva; Dr Coniglio has received funding for a trip from Novartis; Dr. Bresciamorra has received travel payment from Novartis, Biogen Idec, Schering-Plough and Teva. Prof. Savettieri has received travel payment from Teva and honoraria afor scientific lectures from Biogen Idec; Dr. Gallo has received travel payment from Biogen Idec and Schering-Plough and honoraria for scientific lectures from Biogen Idec; Prof. Simone has received honoraria for educational lectures from Biogen Idec, Bayer, Sanofi Aventis-Genzyme and Teva; Prof. Zappia has received funding for a trip from Schering-Plough; Prof. Bonavita has received travel payment from Merck-Serono, Novartis, Biogen Idec and Teva and honoraria for scientific lectures from Novartis; Prof. Tedeschi has received travel payment from Merck-Serono, Novartis, Biogen Idec and Teva and honoraria for scientific lectures from Novartis, Teva and Biogen Idec. Francesco Patti declares, on behalf of all authors, all potential competing interests do not alter their adherence to PLOS ONE policies on sharing data and materials.","2015","03","Francesco Patti","FP",24,TRUE,10,12,4,5,TRUE,TRUE,FALSE,0,NA,FALSE
